Edward C. Stack, Ph.D.

Google:
"Edward Stack"
Mean distance: 35622
 

Parents

Sign in to add mentor
Michael Numan grad student 2002 Boston College
 (A neuroanatomical and molecular analysis of medial preoptic area regulation of maternal behavior in the rat.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tyekucheva S, Martin NE, Stack EC, et al. (2015) Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics : Jmd. 17: 374-81
Bambury RM, Bhatt AS, Riester M, et al. (2015) DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors. Bmc Cancer. 15: 242
Guancial EA, Werner L, Bellmunt J, et al. (2014) FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Medicine. 3: 835-44
Choueiri TK, Jacobus S, Bellmunt J, et al. (2014) Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1889-94
Wagle N, Grabiner BC, Van Allen EM, et al. (2014) Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib. Cancer Discovery. 4: 546-53
Riester M, Werner L, Bellmunt J, et al. (2014) Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1873-83
Lunardi A, Ala U, Epping MT, et al. (2013) A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics. 45: 747-55
Norden AD, Lesser GJ, Drappatz J, et al. (2013) Phase 2 study of dose-intense temozolomide in recurrent glioblastoma. Neuro-Oncology. 15: 930-5
Xu K, Wu ZJ, Groner AC, et al. (2012) EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (New York, N.Y.). 338: 1465-9
Pettersson A, Graff RE, Bauer SR, et al. (2012) The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1497-509
See more...